Drug · DIN 02489597
EVENITY
PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 12, 2019; first marketed August 12, 2019.
- Drug Identification Number (DIN)
- 02489597
- Company (DIN owner)
- Amgen Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Romosozumab M05BX06
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ROMOSOZUMAB | 105 MG | 1.17 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 17, 2019: NOC 22291New Drug Submission (NDS)